Fragrance avoidance
Not a strong fit for fragrance avoidance because it carries Fragrance.
The ingredient itself is a fragrance-linked signal, so it is better treated as an avoid case when fragrance exposure is the main concern.
EPA CPDat observed this chemical in 240 composition records across product categories including Personal care, Construction and building materials, Pesticides.
Concern score
The concern value is driven by the published classifications and regulatory status below — not by a single signal.
Concern score 45/100 (moderate) · high confidence.
Prevalence of HYDROGENATED SOYBEAN OIL in our catalog (epa_cpdat).
Products
240
Brands
6
Typical roles
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Fragrance avoidance
Not a strong fit for fragrance avoidance because it carries Fragrance.
The ingredient itself is a fragrance-linked signal, so it is better treated as an avoid case when fragrance exposure is the main concern.
The published evidence profile currently shaping this ingredient record.
Canonical allergen markers detected on this ingredient. Each row is derived from the ingredient’s name or synonyms matching a known allergen class — useful when scanning a label for a specific allergy context.
Source: chemindex_name_match
Primary documents currently linked to this ingredient record.
Structured claim signals pulled from linked ingredient research.
Published jurisdiction-level classifications and regulatory designations for this ingredient.
US
EPA
EPA CPDat observed this chemical in 240 composition records across product categories including Personal care, Construction and building materials, Pesticides. EPA CPDat classifies this chemical for functional uses including Humectant, Softener and conditioner, Viscosity modifier.
US
FDA
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 95 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Potency: 13.5 mg
US
FDA
Route: ORAL; Dosage form: TABLET, COATED; Potency: 3 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 96 mg
US
FDA
openFDA substance registry classifies this ingredient as structurallydiverse.